Immunohistochemical localization of plasminogen activator inhibitor-1 in human coronary atherosclerotic lesions involved in acute myocardial infarction

This publication has 18 references indexed in Scilit:

• Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries.
  Proceedings of the National Academy of Sciences, 1992
• The plasminogen-plasmin system
  Progress in Cardiovascular Diseases, 1991
• Distribution of plasminogen activator inhibitor (PAI-1) in tissues.
  Journal of Clinical Pathology, 1991
• Serum-derived vitronectin influences the pericellular distribution of type 1 plasminogen activator inhibitor.
  The Journal of cell biology, 1990
• Major circadian fluctuations in fibrinolytic factors and possible relevance to time of onset of myocardial infarction, sudden cardiac death and stroke
  The American Journal of Cardiology, 1988
• EXTRACELLULAR-MATRIX OF CULTURED BOVINE AORTIC ENDOTHELIAL-CELLS CONTAINS FUNCTIONALLY ACTIVE TYPE-1 PLASMINOGEN-ACTIVATOR INHIBITOR
  1987
• Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.
  Circulation, 1987
• Increased Plasma Levels of a Rapid Inhibitor of Tissue Plasminogen Activator in Young Survivors of Myocardial Infarction
  New England Journal of Medicine, 1985
• Plasminogen activator inhibitor in the blood of patients with coronary artery disease.
  BMJ, 1985
• Coronary thrombosis in pathogenesis of acute myocardial infarction. Histopathological study of coronary arteries in 108 necropsied cases using serial section.
  Heart, 1978